Simulation, construction and characterization of a multi-functional thrombolytic agent with anti-thrombosis activity

Abstract

Prourokinase (scu-PA), a thrombolytic agent, was inserted between Gly118 and Ile119 with foreign anti-thrombosis functional motif (Lys-Gly-Asp-Trp-motif) to construct a multi-functional chimeric molecule. The molecular model of a chimera was simulated and predicted. The recombinant chimeric protein was expressed by the baculovirus-insect cell expression system and purified by affinity chromatography. The physico-chemical characteristics of the chimeric molecule were assayed. The thrombolytic activity was determined to be 90000 IU/mg of fibrinolytic special activity by the fibrin-plate method. The anti-thrombosis activities were also assayed with IC₅₀ of 9.6 ?M by an inhibition test of ADP-induced platelet aggregation.

References

1. Astrup T Mullertz S 1952 The fibrinplate method for estimating fibrinolytic activityArch Biochem Biophys40346351. doi:10.1016/0003‐9861(52)90121‐5
2. Bode C Nordt T K Runge M S 1994 Thrombolytic therapy in acute myocardialinfarction-Selected recent developmentsAnn Hematol693539. doi:10.1007/BF02215957
3. Bradford M M 1976 A rapid and sensitive method for quantitation of microgramquantities of protein utilizing the principle of protein-dye-bindingAnal Biochem72248254. doi:10.1016/0003‐2697(76)90527‐3
4. Dennis M S Henzel W J Pitti R M Lipari M T Napier M A Deisher T Bunting S Lazarus R A 1989 Platelet glycoprotein IIb-IIIa proteinantagonists from snake venoms: evidence for a family of platelet-aggregationinhibitorsProc Natl Acad Sci USA8724712478. doi:10.1073/pnas.87.7.2471
5. Eisenberg P R 1993 Mechanisms of reocclusion after coronary thrombolysisZeit Kardiol82(2)175179
6. Gunzler W A Steffens G J Otting F 1982 The primary structure of high molecularmass urokinase from human urineHoppe-Seyler'sZ Physiol Chem363133136
7. Knapp A Degenhardt T Dodt J 1992 Hirudisins Hirudin-derived thrombin inhibitorswith disintegrin activityJ Biol Chem2672423024234
8. O'Rielly D R Miller L K Luckow V A 1992 in Baculovirus expression vectorsA laboratory ManualNew YorkFreeman Inc1529
9. Plow E F Marguerie G Ginsberg M 1987 Fibrinogen fibrinogen receptors and thepeptides that inhibit these interactionsBiochem Pharmacol3640364040. doi:10.1016/0006‐2952(87)90558‐2
10. Rapaport E 1991 Thrombolysis anticoagulation and reocclusionAm J Cardiol681720
11. Scarborough R Rose J W Hsu M A 1991 Barbourin a GPIIb/IIIa-specific integrinantagonist from the venom of Sistrurusm barbouriJ Biol Chem56693599362
12. Shebuski R J Berry D E Bennett D B Storer B L Ali F Samanen J 1989 Demonstration of Ac-Arg-Gly-Asp-Ser-NH2 as an antiaggregatory agentin the dog intracoronary administrationThrombos Haemostas61183188
13. Shebuski R J Stabilito I J Sitko G R Polokoff M H 1990 Acceleration of recombinant tissue-type plasminogen activator inducedthrombolysis and prevention of reocclusion by the combination of heparinand the Arg-Gly-Asp-containing peptide bitistatin in a canine modelof coronary thrombosisCirculation82169177